Inter-relationships of the chronobiotic, melatonin, with leptin and adiponectin: Implications for obesity

Journal of Pineal Research

Volumn 59, Issue 3, 2015, Pages 277-291

  Szewczyk Golec, Karolina ^a   Woźniak, Alina ^a   Reiter, Russel J ^b  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b University of Texas Health Science Center   (United States)

Author keywords

adipokines; adiponectin; chronobiology; leptin; melatonin; obesity; white adipose tissue

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; GLUCOSE; INTRINSIC FACTOR; LEPTIN; LIPID; MELATONIN;

ADIPOSE TISSUE; BIOLOGICAL RHYTHM; CALORIE; CHRONIC INFLAMMATION; CHRONOBIOLOGY; CIRCADIAN RHYTHM; DIET; ENDOCRINE FUNCTION; ENERGY BALANCE; ENERGY METABOLISM; EXPERIMENTAL MODEL; GLUCOSE METABOLISM; HORMONE STRUCTURE; HUMAN; HYPERLEPTINEMIA; HYPOADIPONECTINEMIA; LIPID METABOLISM; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; REVIEW; SLEEP DEPRIVATION; SYNTHESIS; ANIMAL; METABOLISM; WHITE ADIPOSE TISSUE;

ADIPOKINES; ADIPONECTIN; ADIPOSE TISSUE, WHITE; ANIMALS; HUMANS; LEPTIN; MELATONIN; OBESITY;

EID: 84942079615     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12257     Document Type: Review

References (187)

1. Kopelman PG,. Obesity as a medical problem. Nature 2000; 404: 635-643.
2. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894: i-xii, 1-253.
3. Wilkinson KM,. Increasing obesity in children and adolescents: an alarming epidemic. JAAPA 2008; 21: 31-36.
4. Kelly T, Yang W, Chen C-S, et al., Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) 2008; 32: 1431-1437.
5. de Ferranti S, Mozaffarian D,. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem 2008; 54: 945-955.
6. Kershaw EE, Flier JS,. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89: 2548-2556.
7. Kranendonk ME, van Herwaarden JA, Stupkova T, et al., Inflammatory characteristics of distinct abdominal adipose tissue depots relate differently to metabolic risk factors for cardiovascular disease. Distinct fat depots and vascular risk factors. Atherosclerosis 2015; 239: 419-427.
8. Cizza G, Requena M, de Jonge L,. Chronic sleep deprivation and seasonality: implications for the obesity epidemic. J Endocrinol Invest 2011; 34: 793-800.
9. Cappuccio FP, Taggart FM, Kandala NB, et al., Meta-analysis of short sleep duration and obesity in children and adults. Sleep 2008; 31: 619-626.
10. Cardinali DP, Pagano ES, Bernasconi PAS, et al., Disrupted chronobiology of sleep and cytoprotection in obesity: possible therapeutic value of melatonin. Neuro Endocrinol Lett 2011; 32: 588-606.
11. Hasler G, Buysse DJ, Klaghofer R, et al., The association between short sleep duration and obesity in young adults: a 13-year prospective study. Sleep 2004; 27: 661-666.
12. Markwald RR, Melanson EL, Smith MR, et al., Impact of insufficient sleep on total daily energy expenditure, food intake, and weight gain. Proc Natl Acad Sci USA 2013; 110: 5695-5700.
13. Taheri S, Lin L, Austin D, et al., Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med 2004; 1: e62.
14. Gamble KL, Berry R, Frank SJ, et al., Circadian clock control of endocrine factors. Nat Rev Endocrinol 2014; 10: 466-475.
15. Hardeland R, Madrid JA, Tan DX, et al., Melatonin, the circadian multioscillator system and health: the need for detailed analyses of peripheral melatonin signaling. J Pineal Res 2012; 52: 39-166.
16. Cipolla-Neto J, Amaral FG, Afeche SC, et al., Melatonin, energy metabolism, and obesity: a review. J Pineal Res 2014; 56: 371-381.
17. Froy O,. Metabolism and circadian rhythms-implications for obesity. Endocr Rev 2010; 31: 1-24.
18. Reiter RJ, Tan DX, Korkmaz A, et al., Obesity and metabolic syndrome: association with chronodisruption, sleep deprivation, and melatonin suppression. Ann Med 2012; 44: 564-577.
19. Summa KC, Turek FW,. Chronobiology and obesity: interactions between circadian rhythms and energy regulation. Adv Nutr 2014; 5: 3125-3195.
20. Hussein MR, Ahmed OG, Hassan AF, et al., Intake of melatonin is associated with amelioration of physiological changes, both metabolic and morphological pathologies associated with obesity: an animal model. Int J Exp Pathol 2007; 88: 19-29.
21. Kozirõg M, Poliwczak AR, Duchnowicz P, et al., Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome. J Pineal Res 2011; 50: 261-266.
22. Mesri Alamdari N, Mahdavi R, Roshanravan N, et al., A double-blind, placebo-controlled trial related to the effects of melatonin on oxidative stress and inflammatory parameters of obese women. Horm Metab Res 2015; 47: 504-508.
23. Bonnefont-Rousselot D,. Obesity and oxidative stress: potential roles of melatonin as antioxidant and metabolic regulator. Endocr Metab Immune Disord Drug Targets 2014; 14: 159-168.
24. Korkmaz A, Topal T, Tan DX, et al., Role of melatonin in metabolic regulation. Rev Endocr Metab Disord 2009; 4: 261-270.
25. Nduhirabandi F, du Toit EF, Blackhurst D, et al., Chronic melatonin consumption prevents obesity-related metabolic abnormalities and protects the heart against myocardial ischemia and reperfusion injury in a prediabetic model of diet-induced obesity. J Pineal Res 2011; 50: 171-182.
26. Nduhirabandi F, du Toit EF, Lochner A,. Melatonin and the metabolic syndrome: a tool for effective therapy in obesity-associated abnormalities? Acta Physiol (Oxf) 2012; 205: 209-223.
27. Tan DX, Manchester LC, Fuentes-Broto L, et al., Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesity. Obes Rev 2011; 12: 167-188.
28. Tsang AH, Kolbe I, Seemann J, et al., Interaction of circadian and stress systems in the regulation of adipose physiology. Horm Mol Biol Clin Investig 2014; 19: 103-115.
29. Trayhurn P,. Adipocyte biology. Obes Rev 2007; 8: 41-44.
30. Gilsanz V, Hu HH, Kajimura S,. Relevance of brown adipose tissue in infancy and adolescence. Pediatr Res 2013; 73: 3-9.
31. Fenzl A, Kiefer FW,. Brown adipose tissue and thermogenesis. Horm Mol Biol Clin Investig 2014; 19: 25-37.
32. Virtanen KA, Lidell ME, Orava J, et al., Functional brown adipose tissue in healthy adults. N Engl J Med 2009; 360: 1518-1525.
33. Cook KS, Min HY, Johnson D, et al., Adipsin: a circulating serine protease homolog secreted by adipose tissue and sciatic nerve. Science 1987; 237: 402-405.
34. Blüher M, Manizoros CS,. From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century. Metabolism 2015; 64: 131-145.
35. Lehr S, Hartwig S, Lamers D, et al., Identification and validation of novel adipokines released from primary human adipocytes. Mol Cell Proteomics 2012; 11: M111.010504.
36. Lehr S, Hartwig S, Sell H,. Adipokines: a treasure trove for the discovery of biomarkers for metabolic disorders. Proteomics Clin Appl 2012; 6: 91-101.
37. AGUILAR-VALLES A, Inoue W, Rummel C, et al., Obesity, adipokines and neuroinflammation. Neuropharmacology 2015; 96: 124-134.
38. Fain JN,. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm 2006; 74: 443-477.
39. Trayhurn P, Wood IS,. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004; 92: 347-355.
40. Ando H, Yanagihara H, Hayashi Y, et al., Rhythmic messenger ribonucleic acid expression of clock genes and adipocytokines in mouse visceral adipose tissue. Endocrinology 2005; 146: 5631-5636.
41. Barnea M, Chapnik N, Genzer Y, et al., The circadian clock machinery controls adiponectin expression. Mol Cell Endocrinol 2015; 399: 284-287.
42. Gõmez-Santos C, Gõmez-Abellán P, Madrid JA, et al., Circadian rhythm of clock genes in human adipose explants. Obesity (Silver Spring) 2009; 17: 1481-1485.
43. Johnston JD, Frost G, Otway DT,. Adipose tissue, adipocytes and the circadian timing system. Obes Rev 2009; 10: 52-60.
44. Otway DT, Mäntele S, Bretschneider S, et al., Rhythmic diurnal gene expression in human adipose tissue from individuals who are lean, overweight, and type 2 diabetic. Diabetes 2011; 60: 1577-1581.
45. Grimaldi B, Bellet MM, Katada S, et al., PER2 controls lipid metabolism by direct regulation of PPARγ. Cell Metab 2010; 12: 509-520.
46. Guo B, Chatterjee S, Li L, et al., The clock gene, brain and muscle Arnt-like 1, regulates adipogenesis via Wnt signaling pathway. FASEB J 2012; 26: 3453-3463.
47. Johnston JD,. Adipose circadian rhythms: translating cellular and animal studies to human physiology. Mol Cell Endocrinol 2012; 349: 45-50.
48. Hajer GR, van Haeften TW, Visseren FL,. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 2008; 29: 2959-2971.
49. Gealekman O, Guseva N, Hartigan C, et al., Depot-specific differences and insufficient subcutaneous adipose tissue angiogenesis in human obesity. Circulation 2011; 123: 186-194.
50. Lê KA, Mahurkar S, Alderete TL, et al., Subcutaneous adipose tissue macrophage infiltration is associated with hepatic and visceral fat deposition, hyperinsulinemia, and stimulation of NF-κB stress pathway. Diabetes 2011; 60: 2802-2809.
51. Wentworth JM, Naselli G, Brown WA, et al., Pro-inflammatory CD11c+CD206 + adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes 2010; 59: 1648-1656.
52. Antuna-Puente B, Feve B, Fellahi S, et al., Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab 2008; 34: 2-11.
53. Khan M, Joseph F,. Adipose tissue and adipokines: the association with and application of adipokines in obesity. Scientifica (Cairo) 2014; 2014: 328592. doi: 10.1155/2014/328592.
54. LEAL Vde O, Mafra D,. Adipokines in obesity. Clin Chim Acta 2013; 419: 87-94.
55. Agil A, El-Hammadi M, Jiménez-Aranda A, et al., Melatonin reduces hepatic mitochondrial dysfunction in diabetic obese rats. J Pineal Res 2015. doi: 10.1111/jpi.12241 epub ahead of print.
56. Lewy AJ,. Melatonin and human chronobiology. Cold Spring Harb Symp Quant Biol 2007; 72: 623-636.
57. Lockley SW, Brainard GC, Czeisler CA,. High sensitivity of the human circadian melatonin rhythm to resetting by short wavelength light. J Clin Endocrinol Metab 2003; 88: 4502-4505.
58. Ekmecioglu C,. Melatonin receptors in humans: biological role and clinical relevance. Biomed Pharmacother 2006; 60: 97-108.
59. Hardeland R, Cardinali DP, Srinivasan V, et al., Melatonin-a pleiotropic, orchestrating regulator molecule. Prog Neurobiol 2011; 93: 350-384.
60. Kedziora-Kornatowska K, Szewczyk-Golec K, Czuczejko J, et al., Effect of melatonin on the oxidative stress in erythrocytes of healthy young and elderly subjects. J Pineal Res 2007; 42: 153-158.
61. Kedziora-Kornatowska K, Szewczyk-Golec K, Kozakiewicz M, et al., Melatonin improves oxidative stress parameters measured in the blood of elderly type 2 diabetic patients. J Pineal Res 2009; 46: 333-337.
62. Reiter RJ, Tan DX, Galano A,. Melatonin: exceeding expectations. Physiology (Bethesda) 2014; 29: 325-333.
63. Dubocovich ML, Delagrange P, Krause DN, et al., International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors. Pharmacol Rev 2010; 62: 343-380.
64. Bazwinsky-Wutschke I, Bieseke L, Mühlbauer E, et al., Influence of melatonin receptor signalling on parameters involved in blood glucose regulation. J Pineal Res 2014; 56: 82-96.
65. Witt-Enderby PA, Bennett J, Jarzynka MJ, et al., Melatonin receptors and their regulation: biochemical and structural mechanisms. Life Sci 2003; 72: 2183-2198.
66. Nosjean O, Ferro M, Coge F, et al., Identification of the melatonin-binding site MT3 as the quinone reductase 2. J Biol Chem 2000; 275: 31311-31317.
67. Nosjean O, Nicolas JP, Klupsch F, et al., Comparative pharmacological studies of melatonin receptors: MT1, MT2 and MT3/QR2. Tissue distribution of MT3/QR2. Biochem Pharmacol 2001; 61: 1369-1379.
68. Lardone PJ, Guerrero JM, Fernandez-Santos JM, et al., Melatonin synthesized by T lymphocytes as a ligand of the retinoic acid-related orphan receptor. J Pineal Res 2011; 51: 454-462.
69. Slominski RM, Reiter RJ, Schlabritz-Loutsevitch N, et al., Melatonin membrane receptors in peripheral tissues: distribution and functions. Mol Cell Endocrinol 2012; 351: 152-66.
70. Jetten AM,. Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism. Nucl Recept Signal 2009; 7: e003.
71. Benítez-King G,. Melatonin as a cytoskeletal modulator: implications for cell physiology and disease. J Pineal Res 2006; 40: 1-9.
72. Galano A, Tan DX, Reiter RJ,. On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK. J Pineal Res 2013; 54: 245-257.
73. Zhang HM, Zhang Y,. Melatonin: a well-documented antioxidant with conditional pro-oxidant actions. J Pineal Res 2014; 57: 131-146.
74. Lima FB, Matsushita DH, Hell NS, et al., The regulation of insulin action in isolated adipocytes. Role of the periodicity of food intake, time of day and melatonin. Braz J Med Biol Res 1994; 27: 995-1000.
75. Zalatan F, Krause JA, Blask DE,. Inhibition of isoproterenol-induced lipolysis in rat inguinal adipocytes in vitro by physiological melatonin via a receptor-mediated mechanism. Endocrinology 2001; 142: 3783-3790.
76. Brydon L, Petit L, Delagrange P, et al., Functional expression of MT2 (Mel1b) melatonin receptors in human PAZ6 adipocytes. Endocrinology 2001; 142: 4264-4271.
77. Adamczyk-Sowa M, Sowa P, Zwirska-Korczala K, et al., Labeled [3H]-thymidine incorporation in the DNA of 3T3-L1 preadipocytes due to MT2-and not MT3-melatonin receptor. J Physiol Pharmacol 2014; 65: 135-143.
78. le Gouic S, Atgié C, Viguerie-Bascands N, et al., Characterization of a melatonin binding site in Siberian hamster brown adipose tissue. Eur J Pharmacol 1997; 339: 271-278.
79. Bordji K, Grillasca JP, Gouze JN, et al., Evidence for the presence of peroxisome proliferator-activated receptor (PPAR) alpha and gamma and retinoid Z receptor in cartilage. PPARgamma activation modulates the effects of interleukin-1beta on rat chondrocytes. J Biol Chem 2000; 275: 12243-12250.
80. Smirnov AN,. Nuclear melatonin receptors. Biochemistry (Mosc) 2001; 66: 19-26.
81. Bartness TJ, Song CK,. Sympathetic and sensory innervation of white adipose tissue. J Lipid Res 2007; 48: 1655-1672.
82. Vriend CJ, Reiter J,. Melatonin feedback on clock genes: a theory involving the proteasome. J Pineal Res 2015; 58: 1-11.
83. Song CK, Bartness J,. CNS sympathetic outflow neurons to white fat that express MEL receptors may mediate seasonal adiposity. Am J Physiol Regul Integr Comp Physiol 2001; 281: R666-R672.
84. Leitner C, Bartness TJ,. An intact dorsomedial hypothalamic nucleus, but not the subzona incerta or reuniens nucleus, is necessary for short-day melatonin signal-induced responses in Siberian hamsters. Neuroendocrinology 2011; 93: 29-39.
85. Alonso-Vale MI, Andreotti S, Mukai PY, et al., Melatonin and the circadian entrainment of metabolic and hormonal activities in primary isolated adipocytes. J Pineal Res 2008; 45: 422-429.
86. de Farias TD, de Oliveira AC, Andreotti S, et al., Pinealectomy interferes with the circadian clock genes expression in white adipose tissue. J Pineal Res 2015; 58: 251-261.
87. Cardinali DP, Cano P, Jiménez-Ortega V, et al., Melatonin and the metabolic syndrome: physiopathologic and therapeutical implications. Neuroendocrinology 2011; 93: 133-142.
88. Cano P, Jiménez-Ortega V, Larrad A, et al., Effect of a high-fat diet on 24-h pattern of circulating levels of prolactin, luteinizing hormone, testosterone, corticosterone, thyroid-stimulating hormone and glucose, and pineal melatonin content, in rats. Endocrine 2008; 33: 118-125.
89. Jiménez-Aranda A, Fernández-Vázquez G, Campos D, et al., Melatonin induces browning of inguinal white adipose tissue in Zucker diabetic fatty rats. J Pineal Res 2013; 55: 416-423.
90. Ingalls AM, Dickie MM, Snell GD,. Obese, a new mutation in the house mouse. J Hered 1950; 41: 317-318.
91. Janečková R,. The role of leptin in human physiology and pathophysiology. Physiol Res 2001; 50: 443-459.
92. Friedman JM, Leibel RL, Siegel DS, et al., Molecular mapping of the mouse ob mutation. Genomics 1991; 11: 1054-1062.
93. Zhang Y, Proenca R, Maffei M, et al., Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432.
94. White DW, Tartaglia LA,. Leptin and OB-R: body weight regulation by a cytokine receptor. Cytokine Growth Factor Rev 1996; 7: 303-309.
95. Park HK, Ahima RS,. Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism. Metabolism 2015; 64: 24-34.
96. Gündüz B,. Daily rhythm in serum melatonin and leptin levels in the Syrian hamster (Mesocricetus auratus). Comp Biochem Physiol A Mol Integr Physiol 2002; 132: 393-401.
97. Licinio J, Mantzoros C, Negrão AB, et al., Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nat Med 1997; 3: 575-579.
98. Mastronardi CA, Walczewska A, Yu WH, et al., The possible role of prolactin in the circadian rhythm of leptin secretion in male rats. Proc Soc Exp Biol Med 2000; 224: 152-158.
99. Yildiz BO, Suchard MA, Wong ML, et al., Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity. Proc Natl Acad Sci USA 2004; 101: 10434-10439.
100. Orel M, Lichnovská R, Gwozdziewiczová S, et al., Gender differences in tumor necrosis factor alpha and leptin secretion from subcutaneous and visceral fat tissue. Physiol Res 2004; 53: 501-505.
101. Dardeno TA, Chou SH, Moon HS, et al., Leptin in human physiology and therapeutics. Front Neuroendocrinol 2010; 31: 377-393.
102. Alonso-Vale MI, Anhê GF, Borges-Silva Cd, et al., Pinealectomy alters adipose tissue adaptability to fasting in rats. Metabolism 2004; 53: 500-506.
103. Tartaglia LA, Dembski M, Weng X, et al., Identification and expression cloning of a leptin receptor, OB-R. Cell 1995; 83: 1263-1271.
104. Lee GH, Proenca R, Montez JM, et al., Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996; 379: 632-635.
105. Bjørbaek C, Kahn BB,. Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res 2004; 59: 305-331.
106. Sáinz N, Barrenetxe J, Moreno-Aliaga MJ, et al., Leptin resistance and diet-induced obesity: central and peripheral actions of leptin. Metabolism 2015; 64: 35-46.
107. van Swieten MM, Pandit R, Adan RA, et al., The neuroanatomical function of leptin in the hypothalamus. J Chem Neuroanat 2014; 61-62: 207-220.
108. Chelikani PK, Glimm DR, Kennelly JJ,. Short communication: Tissue distribution of leptin and leptin receptor mRNA in the bovine. J Dairy Sci 2003; 86: 2369-2372.
109. Rezai-Zadeh K, Yu S, Jiang Y, et al., Leptin receptor neurons in the dorsomedial hypothalamus are key regulators of energy expenditure and body weight, but not food intake. Mol Metab 2014; 3: 681-693.
110. Klok MD, Jakobsdottir S, Drent ML,. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obes Rev 2007; 8: 21-34.
111. Sahu A,. Resistance to the satiety action of leptin following chronic central leptin infusion is associated with the development of leptin resistance in neuropeptide Y neurones. J Neuroendocrinol 2002; 14: 796-804.
112. Kelesidis T, Kelesidis I, Chou S, et al., Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Intern Med 2010; 152: 93-100.
113. Knight ZA, Hannan KS, Greenberg ML, et al., Hyperleptinemia is required for the development of leptin resistance. PLoS One 2010; 5: e11376.
114. Howard JK, Flier JS,. Attenuation of leptin and insulin signaling by SOCS proteins. Trends Endocrinol Metab 2006; 17: 365-371.
115. Yang Z, Hulver M, McMILLAN RP, et al., Regulation of insulin and leptin signaling by muscle suppressor of cytokine signaling 3 (SOCS3). PLoS One 2012; 7: e47493.
116. Picinato MC, Hirata AE, Cipolla-Neto J, et al., Activation of insulin and IGF-1 signaling pathways by melatonin through MT1 receptor in isolated rat pancreatic islets. J Pineal Res 2008; 44: 88-94.
117. Alonso-Vale MI, Andreotti S, Borges-Silva Cd, et al., Intermittent and rhythmic exposure to melatonin in primary cultured adipocytes enhances the insulin and dexamethasone effects on leptin expression. J Pineal Res 2006; 41: 28-34.
118. Agil A, Rosado I, Ruiz R, et al., Melatonin improves glucose homeostasis in young Zucker diabetic fatty rats. J Pineal Res 2012; 52: 203-210.
119. Canpolat S, Sandal S, Yilmaz B, et al., Effects of pinealectomy and exogenous melatonin on serum leptin levels in male rat. Eur J Pharmacol 2001; 428: 145-148.
120. de Oliveira AC, Andreotti S, Farias TDAS, et al., Metabolic disorders and adipose tissue insulin responsiveness in neonatally STZ-induced diabetic rats are improved by long-term melatonin treatment. Endocrinology 2012; 153: 2178-2188.
121. Kitagawa A, Ohta Y, Ohashi K,. Melatonin improves metabolic syndrome induced by high fructose intake in rats. J Pineal Res 2012; 52: 403-413.
122. Prunet-Marcassus B, Desbazeille M, Bros A, et al., Melatonin reduces body weight gain in Sprague Dawley rats with diet-induced obesity. Endocrinology 2003; 144: 5347-5352.
123. Puchalski SS, Green JN, Rasmussen DD,. Melatonin effect on rat body weight regulation in response to high-fat diet at middle age. Endocrine 2003; 21: 163-167.
124. Rasmussen DD, Boldt BM, Wilkinson CW, et al., Daily melatonin administration at middle age suppresses male rat visceral fat, plasma leptin, and plasma insulin to youthful levels. Endocrinology 1999; 140: 1009-1012.
125. Wolden-Hanson T, Mitton DR, McCants RL, et al., Daily melatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat. Endocrinology 2000; 141: 487-497.
126. Baydas G, Gursu F, Canpolat S, et al., Effects of pinealectomy on the circadian release pattern of leptin in male rat. Neuro Endocrinol Lett 2001; 22: 449-452.
127. Alonso-Vale MI, Peres SB, Vernochet C, et al., Adipocyte differentiation is inhibited by melatonin through the regulation of C/EBPbeta transcriptional activity. J Pineal Res 2009; 47: 221-227.
128. Zaminy A, Kashani IR, Barbarestani M, et al., Effects of melatonin on the proliferation and differentiation of rat adipose-derived stem cells. Indian J Plast Surg 2008; 41: 8-14.
129. Zhang L, Su P, Xu C, et al., Melatonin inhibits adipogenesis and enhances osteogenesis of human mesenchymal stem cells by suppressing PPARγ expression and enhancing Runx2 expression. J Pineal Res 2010; 49: 364-372.
130. Baltaci AK, Mogulkoc R,. Pinealectomy and melatonin administration in rats: their effects on plasma leptin levels and relationship with zinc. Acta Biol Hung 2007; 58: 335-343.
131. Ríos-Lugo MJ, Cano P, Jiménez-Ortega V, et al., Melatonin effect on plasma adiponectin, leptin, insulin, glucose, triglycerides and cholesterol in normal and high fat-fed rats. J Pineal Res 2010; 49: 342-348.
132. Song YM, Chen MD,. Effects of melatonin administration on plasma leptin concentration and adipose tissue leptin secretion in mice. Acta Biol Hung 2009; 60: 399-407.
133. Ríos-Lugo MJ, Jiménez-Ortega V, Cano-Barquilla P, et al., Melatonin counteracts changes in hypothalamic gene expression of signals regulating feeding behavior in high-fat fed rats. Horm Mol Biol Clin Investig 2015; 21: 175-183.
134. Corbalán-Tutau D, Madrid JA, Nicolás F, et al., Daily profile in two circadian markers "melatonin and cortisol" and associations with metabolic syndrome components. Physiol Behav 2014; 123: 231-235.
135. Mäntele S, Otway DT, Middleton B, et al., Daily rhythms of plasma melatonin, but not plasma leptin or leptin mRNA, vary between lean, obese and type 2 diabetic men. PLoS One 2012; 7: e37123.
136. Gonciarz M, Bielański W, Partyka R, et al., Plasma insulin, leptin, adiponectin, resistin, ghrelin, and melatonin in nonalcoholic steatohepatitis patients treated with melatonin. J Pineal Res 2013; 54: 154-161.
137. Celinski K, Konturek PC, Slomka M, et al., Altered basal and postprandial plasma melatonin, gastrin, ghrelin, leptin and insulin in patients with liver cirrhosis and portal hypertension without and with oral administration of melatonin or tryptophan. J Pineal Res 2009; 46: 408-414.
138. Cagnacci A, Malmusi S, Zanni A, et al., Acute modifications in the levels of daytime melatonin do not influence leptin in postmenopausal women. J Pineal Res 2002; 33: 57-60.
139. Zieba DA, Kirsz K, Molik E, et al., Effects of orexigenic peptides and leptin on melatonin secretion during different photoperiods in seasonal breeding ewes: an in vitro study. Domest Anim Endocrinol 2011; 40: 139-146.
140. Peliciari-Garcia RA, Andrade-Silva J, Cipolla-Neto J, et al., Leptin modulates norepinephrine-mediated melatonin synthesis in cultured rat pineal gland. Biomed Res Int 2013; 2013: 546516.
141. Scherer PE, Williams S, Fogliano M, et al., A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995; 270: 26746-26749.
142. Hu E, Liang P, Spiegelman BM,. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996; 271: 10697-10703.
143. Maeda K, Okubo K, Shimomura I, et al., cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 1996; 221: 286-289.
144. Nakano Y, Tobe T, Choi-Miura NH, et al., Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem (Tokyo) 1996; 120: 803-812.
145. Berner HS, Lyngstadaas SP, Spahr A, et al., Adiponectin and its receptors are expressed in bone-forming cells. Bone 2004; 35: 842-849.
146. Thundyil J, Pavlovski D, Sobey CG, et al., Adiponectin receptor signaling in the brain. Br J Pharmacol 2012; 165: 313-327.
147. Lihn AS, Bruun JM, He G, et al., Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol 2004; 219: 9-15.
148. Wang Y, Xu A, Knight C, et al., Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin. Potential role in the modulation of its insulin-sensitizing activity. J Biol Chem 2002; 277: 19521-19529.
149. Berg AH, Combs TP, Scherer PE,. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002; 13: 84-89.
150. Chandran M, Phillips SA, Ciaraldi T, et al., Adiponectin: more than just another fat cell hormone? Diabetes Care 2003; 26: 2442-2450.
151. Trujillo ME, Scherer PE,. Adiponectin- journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 2005; 257: 167-175.
152. Fruebis J, Tsao TS, Javorschi S, et al., Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 2001; 98: 2005-2010.
153. Waki H, Yamauchi T, Kamon J, et al., Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem 2003; 278: 40352-40363.
154. Silva TE, Colombo G, Schiavon LL,. Adiponectin: a multitasking player in the field of liver diseases. Diabetes Metab 2014; 40: 95-107.
155. Kennaway DJ, Owens JA, Voultsios A, et al., Metabolic homeostasis in mice with disrupted Clock gene expression in peripheral tissues. Am J Physiol Regul Integr Comp Physiol 2007; 293: R1528-R1537.
156. Wolk R, Berger P, Lennon RJ, et al., Association between plasma adiponectin levels and unstable coronary syndromes. Eur Heart J 2007; 8: 292-298.
157. Scheer FA, Chan JL, Fargnoli J, et al., Day/night variations of high-molecular-weight adiponectin and lipocalin-2 in healthy men studied under fed and fasted conditions. Diabetologia 2010; 53: 2401-2405.
158. Kennaway DJ, Owens JA, Voultsios A, et al., Adipokines and adipocyte function in Clock mutant mice that retain melatonin rhythmicity. Obesity (Silver Spring) 2012; 20: 295-305.
159. Yamauchi T, Kamon J, Ito Y, et al., Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003; 423: 762-769.
160. Tang YT, Hu T, Arterburn M, et al., PAQR proteins: a novel membrane receptor family defined by an ancient 7-transmembrane pass motif. J Mol Evol 2005; 61: 372-380.
161. Yamauchi T, Iwabu M, Okada-Iwabu M, et al., Adiponectin receptors: a review of their structure, function and how they work. Best Pract Res Clin Endocrinol Metab 2014; 28: 15-23.
162. Guillod-Maximin E, Roy AF, Vacher CM, et al., Adiponectin receptors are expressed in hypothalamus and colocalized with proopiomelanocortin and neuropeptide Y in rodent arcuate neurons. J Endocrinol 2009; 200: 93-105.
163. Fisman EZ, Tenenbaum A,. Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease? Cardiovasc Diabetol 2014; 13: 103.
164. Blüher M, Fasshauer M, Kralisch S, et al., Regulation of adiponectin receptor R1 and R2 gene expression in adipocytes of C57BL/6 mice. Biochem Biophys Res Commun 2005; 329: 1127-1132.
165. Hug C, Wang J, Ahmad NS, et al., T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc Natl Acad Sci USA 2004; 101: 10308-10313.
166. Takeuchi T, Adachi Y, Ohtsuki Y, et al., Adiponectin receptors, with special focus on the role of the third receptor, T-cadherin, in vascular disease. Med Mol Morphol 2007; 40: 115-120.
167. Cheng KK, Lam KS, Wang B, et al., Signaling mechanisms underlying the insulin-sensitizing effects of adiponectin. Best Pract Res Clin Endocrinol Metab 2014; 28: 3-13.
168. Kubota N, Yano W, Kubota T, et al., Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab 2007; 6: 55-68.
169. Liu M, Liu F,. Regulation of adiponectin multimerization, signaling and function. Best Pract Res Clin Endocrinol Metab 2014; 28: 25-31.
170. Cong L, Gasser J, Zhao J, et al., Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95 2. Endocr Relat Cancer 2007; 14: 713-720.
171. Esmaili S, Xu A, George J,. The multifaceted and controversial immunometabolic actions of adiponectin. Trends Endocrinol Metab 2014; 25: 444-451.
172. Liao W, Yu C, Wen J, et al., Adiponectin induces interleukin-6 production and activates STAT3 in adult mouse cardiac fibroblasts. Biol Cell 2009; 101: 263-272.
173. Tsatsanis C, Zacharioudaki V, Androulidaki A, et al., Adiponectin induces TNF-alpha and IL-6 in macrophages and promotes tolerance to itself and other pro-inflammatory stimuli. Biochem Biophys Res Commun 2005; 335: 1254-1263.
174. Wan Z, Mah D, Simtchouk S, et al., Globular adiponectin induces a pro-inflammatory response in human astrocytic cells. Biochem Biophys Res Commun 2014; 446: 37-42.
175. Silva-Nunes J, Oliveira A, Duarte L, et al., Factors related with adiponectinemia in obese and normal-weight women and with its variation in weight loss programs. Obes Facts 2013; 6: 124-133.
176. Yang WS, Lee WJ, Funahashi T, et al., Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001; 86: 3815-3819.
177. Barnea M, Madar Z, Froy O,. High-fat diet followed by fasting disrupts circadian expression of adiponectin signaling pathway in muscle and adipose tissue. Obesity (Silver Spring) 2010; 18: 230-238.
178. Cano P, Cardinali DP, Ríos-Lugo MJ, et al., Effect of a high-fat diet on 24-hour pattern of circulating adipocytokines in rats. Obesity (Silver Spring) 2009; 17: 1866-1871.
179. Calvani M, Scarfone A, Granato L, et al., Restoration of adiponectin pulsatility in severely obese subjects after weight loss. Diabetes 2004; 53: 939-947.
180. Chung SH, PARK YS, KIM OS, et al., Melatonin attenuates dextran sodium sulfate induced colitis with sleep deprivation: possible mechanism by microarray analysis. Dig Dis Sci 2014; 59: 1134-1141.
181. Agabiti-Rosei C, de Ciuceis C, Rossini C, et al., Anticontractile activity of perivascular fat in obese mice and the effect of long-term treatment with melatonin. J Hypertens 2014; 32: 1264-1274.
182. Huang L, Zhang C, Hou Y, et al., Blood pressure reducing effects of piromelatine and melatonin in spontaneously hypertensive rats. Eur Rev Med Pharmacol Sci 2013; 17: 2449-2456.
183. Nduhirabandi F, Huisamen B, Strijdom H, et al., Short-term melatonin consumption protects the heart of obese rats independent of body weight change and visceral adiposity. J Pineal Res 2014; 57: 317-332.
184. Naderali EK, Estadella D, Rocha M, et al., A fat-enriched, glucose-enriched diet markedly attenuates adiponectin mRNA levels in rat epididymal adipose tissue. Clin Sci (Lond) 2003; 105: 403-408.
185. Milan G, Granzotto M, Scarda A, et al., Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss. Obes Res 2002; 10: 1095-1103.
186. Paradies G, Paradies V, Ruggiero FM, et al., Protective role of melatonin in mitochondrial dysfunction and related disorders. Arch Toxicol 2015; 89: 923-939.
187. Matsubar M, Maruoka S, Katayose S,. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol 2002; 147: 173-180.